|
Adams Street Partners LLC |
Private equity and venture capital fund of funds |
United States |
+1 (312) 553-7890 |
N/A |
|
|
|
Bay Partners LLC |
|
United States |
+1 (650) 854-1500 |
N/A |
|
|
|
Bay Partners LLC |
|
United States |
+1 (650) 854-1500 |
Series B |
|
|
|
De Novo Ventures |
|
United States |
+1 (650) 329-1999 |
Series B |
|
|
|
Delphi Ventures Inc |
Venture capital firm with a focus on early stage investing in medical devices and biotechnology |
United States |
+1 (650) 854-9650 |
N/A |
|
|
|
Genentech Inc |
Discovery, development, commercialization and manufacturing of biotherapeutics by using human genetic information |
United States |
|
N/A |
|
|
|
Latterell Venture Partners (LVP) |
|
United States |
+1 (415) 399-9880 |
Series B |
|
|
|
Latterell Venture Partners (LVP) |
|
United States |
+1 (415) 399-9880 |
Series A |
|
|
|
Morgenthaler Management Partners (Morgenthaler Ventures), (Morgenthaler Partners) |
One of the oldest private equity investment firms in the US investing through both venture capital and leverage buyout transactions. |
United States |
+1 (650) 388-7600 |
Series A |
|
|
|
Morgenthaler Management Partners (Morgenthaler Ventures), (Morgenthaler Partners) |
One of the oldest private equity investment firms in the US investing through both venture capital and leverage buyout transactions. |
United States |
+1 (650) 388-7600 |
Series B |
|
|
|
Nomura Phase4 Ventures LP |
|
United Kingdom |
|
N/A |
|
|
|
Phase4 Ventures Ltd |
|
United Kingdom |
+44 (20) 3036-0050 |
Series B |
|
|
|
SR One Ltd |
The venture capital unit of GlaxoSmithKline |
United States |
+1 (610) 567-1000 |
N/A |
|
|
|
The Vertical Group Inc |
|
United States |
+1 (650) 566-9060 |
Series B |
|
|
|
The Vertical Group Inc |
|
United States |
+1 (650) 566-9060 |
Series A |
|
|
|
TriplePoint Capital |
|
United States |
+1 (650) 854-2090 |
N/A |
|
|
|
US Venture Partners. (USVP) |
Silicon Valley venture capital firm. |
United States |
+1 (650) 854-9080 |
Series A |
|
|
|
US Venture Partners. (USVP) |
Silicon Valley venture capital firm. |
United States |
+1 (650) 854-9080 |
Series B |
|
|